banner

Request Reader Training


Cerianna (fluoroestradiol F 18) injection is an estrogen-receptor targeted radiotracer (e-RTR) prescribed to detect whole-body ER+ lesions in recurrent or metastatic breast cancer patients that may inform clinical decisions.


GE Healthcare has designed peer-to-peer reader training programs in a variety of formats to help you accurately interpret Cerianna images.

We offer convenient virtual training to fit your learning style and schedule.


Register using the form below to request a training session. You will be contacted by our training team within 48 hours.



Request Training


GE Healthcare | Privacy Policy | Terms of Use | Contact Us | Unsubscribe

500 W. Monroe Street | Chicago, IL 60661

 

© 2022 General Electric Company

GE and the GE Monogram are trademarks of the General Electric Company.


JB07297US October/2022